Nivestym (filgrastim-aafi) Injection 300 mcg/0.5 mL Prefilled Syringe, Single-Dose, Each
Nivestym is a biosimilar to Neupogen (filgrastim), a leukocyte growth factor used to reduce the incidence of infection in patients with non-myeloid malignancies receiving myelosuppressive chemotherapy. This presentation is a single-dose prefilled syringe containing 300 mcg of filgrastim-aafi in 0.5 mL of solution, ready for subcutaneous or intravenous administration. Each syringe is individually packaged for single use.
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Nivestym is a biosimilar to Neupogen (filgrastim), a leukocyte growth factor used to reduce the incidence of infection in patients with non-myeloid malignancies receiving myelosuppressive chemotherapy. This presentation is a single-dose prefilled syringe containing 300 mcg of filgrastim-aafi in 0.5 mL of solution, ready for subcutaneous or intravenous administration. Each syringe is individually packaged for single use.
1 vendor
